An analysis of the role of targeted muscle reinnervation (TMR) in quality of life and pain outcomes: a case series

Abstract

Aim: Targeted muscle reinnervation (TMR) surgery has fundamentally changed the management of patients who have suffered or are about to undergo amputation. Providing nerve stumps with a muscle target has been shown to have profound effects on levels of post-amputation pain in relation to phantom limb pain (PLP) and neuroma pain (NP). The primary objective of this report was to quantify pain parameters for this population and to measure the impact on health-related quality of life (HRQol) before and after TMR surgery. In this case series, we evaluate the role of TMR in addressing both pain and the impact of the surgery on the patient’s quality of life.

Methods: A retrospective analysis of 15 upper limb amputee patients who underwent TMR by the Relimb Unit in London, UK. Participants’ perceptions of pain were determined using the 11-point numerical (Pain) rating scale (NRS) and HRQoL was calculated using the Euroqol EQ-5D-5L questionnaire at two time points, comparing both pain and perceived quality of life pre and post surgery. The Wilcoxon Signed Rank Test was used for the NRS data and a paired sample t-test was used for the EQ-VAS data.

Results: A total of 15 patients completed the evaluation. We observed statistically significant reductions in both PLP (pre-operative mean: 7.6, post-operative mean: 2.7, P < 0.05) and NP (pre-operative mean: 6.4, post-operative mean: 2.5, P < 0.05) in these patients. Similarly, HRQoL observed on the EQ-VAS scale demonstrated a significant improvement in quality of life, from 68 pre-operatively to 78 post-procedure (P < 0.05).

Conclusion: This is the first quantified evaluation of changes in HRQoL after TMR surgery for upper limb amputation. There appears to be a significant improvement in both HRQoL and overall perception of pain. This finding may have important implications for funding and national resource allocation for TMR surgery.

Keywords

Amputation / TMR / targeted muscle reinnervation / quality of life / QALY

References

[1] Specialised Commissioning Team NE. Hand and upper limb reconstruction using vascularised composite allotransplantation (HAUL-VCA). Available from: https://www.england.nhs.uk/wp-content/uploads/2018/07/Hand-and-upper-limb-reconstruction-using-vascularised-composite-allotransplantation.pdf [Last accessed on 16 Mar 2023]

[2] Roșca AC,Burtăverde V.Psychological consequences in patients with amputation of a limb. An interpretative-phenomenological analysis.Front Psychol2021;12:537493 PMCID:PMC8189153

[3] Resnik L,Clark M.Function and quality of life of unilateral major upper limb amputees: effect of prosthesis use and type.Arch Phys Med Rehabil2020;101:1396-406

[4] Efanov JI,Izadpanah A,Danino MA.A review of utilities and costs of treating upper extremity amputations with vascularized composite allotransplantation versus myoelectric prostheses in Canada.JPRAS Open2022;32:150-60 PMCID:PMC8989691

[5] Blough DK,McFarland Lv,Gambel JM.Prosthetic cost projections for servicemembers with major limb loss from vietnam and OIF/OEF.J Rehabil Res Dev2010;47:387-402

[6] Wartan SW,Wedley JR.Phantom pain and sensation among British veteran amputees.Br J Anaesth1997;652:121-9

[7] Hsu E.Postamputation pain: epidemiology, mechanisms, and treatment.J Pain Res2013;6:121-36 PMCID:PMC3576040

[8] Collins KL,Schumacher PJ.A review of current theories and treatments for phantom limb pain..J Clin Invest2018;2168:121-76 PMCID:PMC5983333

[9] Kim M,Ryu GW.Functional status and health-related quality of life in patients with peripheral artery disease: a cross-sectional study.Int J Environ Res Public Health2021;18:10941 PMCID:PMC8535998

[10] Bennett DL.Informed drug choices for neuropathic pain.Lancet Neurol2015;14:129-30

[11] Dumanian GA,Mioton LM.Targeted muscle reinnervation treats neuroma and phantom pain in major limb amputees: a randomized clinical trial.Ann Surg2019;270:238-46

[12] Souza JM,Ko JH,Kuiken TA.Targeted muscle reinnervation: a novel approach to postamputation neuroma pain.Clin Orthop Relat Res2014;472:2984-90 PMCID:PMC4160494

[13] Kang NV,Michno DA,Tan J.A consecutive series of targeted muscle reinnervation (TMR) cases for relief of neuroma and phantom limb pain: UK perspective.J Plast Reconstr Aesthet Surg2022;75:960-9

[14] NICE. Position statement on use of the EQ-5D-5L value set for England (updated October 2019). Available from: https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/eq-5d-5l [Last accessed on 16 Mar 2023]

[15] Ernstsson O,Janssen MF,Korkmaz S.Health-related quality of life in patients with lower limb amputation-an assessment of the measurement properties of EQ-5D-3L and EQ-5D-5L using data from the Swedish Amputation and Prosthetics Registry.Disabil Rehabil2022;44:8471-9

[16] Vakhshori V,Mayfield CK,Stevanovic M.Trends in pediatric traumatic upper extremity amputations.Hand2019;14:782-90 PMCID:PMC6900692

[17] Bullinger M.Quality of life as patient-reported outcomes: principles of assessment..Dialogues Clin Neurosci2014;16:137-45 PMCID:PMC4140508

[18] Lawson A,Naylor J.Is retrospective assessment of health-related quality of life valid?.BMC Musculoskelet Disord2020;21 PMCID:PMC7329482